Disc Medicine (IRON) Is Up 8.6% After Wider 2025 Losses And New Shelf Registration - What's Changed [Yahoo! Finance]
Disc Medicine, Inc. (IRON)
Company Research
Source: Yahoo! Finance
share from continuing operations increasing to US$6.01 from US$3.96 a year earlier. On the same day, the company filed a US$108.71 million shelf registration for 1,625,179 common shares tied to its employee stock plans, underscoring ongoing funding needs as it advances multiple hematology programs through the clinic. We will now examine how Disc Medicine's widening losses alongside the new shelf registration shape the company's investment narrative for investors. Outshine the giants: these 22 early-stage AI stocks could fund your retirement What Is Disc Medicine's Investment Narrative? To own Disc Medicine today, you have to be comfortable backing a cash-consuming, clinical-stage story where everything revolves around bitopertin in EPP and the broader hematology pipeline. The latest results put the full-year net loss at US$212.18 million, highlighting how expensive it is to run multiple mid- to late-stage trials without any revenue. At the same time, the new US$108.71 millio
Show less
Read more
Impact Snapshot
Event Time:
IRON
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
IRON alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
IRON alerts
High impacting Disc Medicine, Inc. news events
Weekly update
A roundup of the hottest topics
IRON
News
- INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Disc Medicine, Inc. - IRONGlobeNewswire
- Disc Medicine (IRON) had its price target raised by Wells Fargo & Company from $78.00 to $79.00. They now have an "overweight" rating on the stock.MarketBeat
- Disc Medicine CFO Sells $720k Worth of Shares Amid FDA Rejection [Yahoo! Finance]Yahoo! Finance
- Disc Medicine (IRON) had its price target lowered by Truist Financial Corporation from $114.00 to $83.00. They now have a "buy" rating on the stock.MarketBeat
- INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Disc Medicine, Inc.- IRONPR Newswire
IRON
Earnings
- 2/26/26 - Miss
IRON
Sec Filings
- 3/2/26 - Form 144
- 2/27/26 - Form 4
- 2/27/26 - Form 8-K
- IRON's page on the SEC website